Dimethyl phthalate triggers oxidative stress and inflammation in lung cells

Dimethyl phthalate, a chemical compound found in everything from nail polish and hairspray to insect repellents, textiles and surface coatings, has long been treated as a relatively benign presence in everyday consumer products. New laboratory research now suggests that when this ubiquitous phthalate ester reaches the delicate epithelial lining of the lungs, it can inflict damage that mirrors the earliest cellular events seen in chronic obstructive pulmonary disease, or COPD. The findings, published in Molecular Biology Reports, add a pulmonary dimension to the growing list of health concerns surrounding phthalates, a class of plasticizers and additives that regulators have increasingly flagged as emerging contaminants of priority.

The study, led by Fariya Khan and colleagues at the Stem Cell Research Centre of the Department of Hematology at Sanjay Gandhi Postgraduate Institute of Medical Sciences in Lucknow, together with investigators at the ICMR-National Institute for Research in Environmental Health in Bhopal, set out to address a conspicuous gap in the toxicological literature. Although phthalates are absorbed primarily through ingestion, skin contact and inhalation, and although population studies have repeatedly linked phthalate burdens to reduced lung function, asthma exacerbation and respiratory morbidity, direct experimental data on how dimethyl phthalate, commonly abbreviated DMP, injures lung tissue have remained scarce. Because inhalation is a major route of human exposure, the team chose to model the lung’s first line of contact with inhaled pollutants: the alveolar epithelial barrier.

To do this, the researchers used A549 cells, a human lung adenocarcinoma-derived cell line that behaves much like the type II alveolar epithelial cells lining the air sacs of the lung. These cells form a critical defensive barrier between the outside world and the bloodstream, and their dysfunction is a well-recognized harbinger of chronic airway disease. The investigators exposed the cells to a range of DMP concentrations over varying durations, then interrogated the cells with a battery of complementary techniques designed to capture different dimensions of cellular injury.

The results were striking. Under phase-contrast microscopy, exposed cells displayed visible morphological deterioration, rounding and detaching as the chemical’s concentration and the length of exposure increased. Cell viability, measured with the MTT assay, an established colorimetric test that gauges the metabolic activity of living cells, declined in a clear dose- and time-dependent fashion. In practical terms, the more DMP the cells encountered and the longer they endured it, the fewer of them survived. The pattern of cell death mattered as much as its extent. Flow cytometric analysis using Annexin V and propidium iodide staining, a method that distinguishes the orderly programmed death known as apoptosis from the messier rupture of necrosis, indicated that DMP drove the cells predominantly toward necrotic death. Necrosis is significant in the lung because it releases intracellular contents that can further inflame surrounding tissue, potentially amplifying injury well beyond the cells that are directly killed.

Behind that cytotoxicity, the study found, lay a burst of oxidative stress. Using DCFH-DA, a fluorescent probe that lights up in the presence of intracellular reactive oxygen species, and MitoSOX, a dye engineered to report specifically on superoxide generation inside mitochondria, the team documented a substantial rise in both general cellular oxidants and mitochondrial superoxide. This distinction is technically important. Mitochondria are not merely cellular power plants; in lung biology they act as signaling hubs whose dysfunction can tip cells toward inflammation and death. When the electron transport chain is perturbed, superoxide accumulates, membranes are peroxidized and the cell’s redox balance collapses. The DMP-exposed cells showed precisely this mitochondrial signature, suggesting that the chemical attacks the energy-producing machinery of alveolar epithelium rather than simply poisoning the cell membrane from outside.

Oxidative stress, in turn, is a recognized trigger for inflammatory signaling. Reactive oxygen species activate transcription factors such as nuclear factor kappa B, or NF-κB, which switches on genes encoding pro-inflammatory cytokines. That is exactly what the researchers observed at the molecular level. Quantitative real-time PCR, which measures messenger RNA abundance, revealed significantly elevated expression of tumor necrosis factor alpha, interleukin-6 and interleukin-8 in DMP-treated cells. Enzyme-linked immunosorbent assays confirmed that at least two of these cytokines, IL-6 and IL-8, were secreted in greater quantities into the surrounding medium, meaning the injured cells were actively broadcasting inflammatory signals to their environment rather than merely harboring them internally.

The cytokine triad identified in this study is not arbitrary. TNF-α, IL-6 and IL-8 are among the signature inflammatory mediators detected in the sputum and airways of patients with COPD, a progressive lung disease that ranks among the leading causes of death worldwide and is characterized by persistent airflow limitation, chronic inflammation and irreversible structural remodeling of the small airways. IL-8 in particular acts as a chemoattractant that recruits neutrophils into the lung, while IL-6 sustains systemic and local inflammatory loops. The fact that a common consumer chemical can coax lung epithelial cells toward this same inflammatory program, without any virus, smoke or allergen present, is the finding most likely to trouble environmental health researchers.

Perhaps the most provocative result concerns fibronectin. This high-molecular-weight glycoprotein is a scaffold component of the extracellular matrix, and its accumulation is a hallmark of tissue remodeling and fibrosis. The study found that DMP exposure enhanced both the expression and the extracellular accumulation of fibronectin in the A549 cultures, as assessed by RT-qPCR, ELISA and immunocytochemistry. In the context of chronic lung disease, small-airway fibrosis driven by aberrant epithelial-mesenchymal crosstalk is considered a key structural lesion that fixes airflow obstruction in place. Epithelial cells that are injured or stressed can transition toward a mesenchymal-like phenotype and deposit matrix proteins, thickening the airway wall and stiffening the tissue. The DMP-induced fibronectin buildup observed in vitro therefore hints at a plausible mechanism by which chronic phthalate inhalation could contribute to the remodeling responses implicated in COPD, although the authors are careful to frame this as overlap with disease pathways rather than proof of causation.

The epidemiological backdrop gives these cellular findings added weight. Analyses of large national survey cohorts, including NHANES data from 2007 to 2012, have associated higher phthalate exposure with reduced pulmonary function in adults, and urinary phthalate metabolite mixtures have been linked to diminished lung function in adolescents. Randomized human exposure work with dibutyl phthalate, a chemically related ester, has shown that inhalation exposure can worsen allergen-induced declines in lung function and alter airway immunology. Phthalates are also semi-volatile and abundantly present in house dust, meaning indoor air can carry measurable concentrations, and infants and children may face especially high exposure in their homes. Meanwhile, dimethyl phthalate has been shown to permeate human skin in laboratory models, adding a dermal route to the inhalation and dietary pathways that already concern exposure scientists.

What makes DMP particularly vexing from a regulatory standpoint is its dual identity as a low-molecular-weight phthalate that is not classified in the same restricted category as the better-studied di(2-ethylhexyl) phthalate, yet is arguably more volatile and therefore more available for inhalation. It is formulated into insect repellents, applied in lacquers and coatings, and released from consumer goods into indoor air. The new study’s demonstration that it kills alveolar epithelial cells, floods them with mitochondrial superoxide, provokes a COPD-like cytokine profile and drives fibronectin deposition collectively sketches a coherent mechanism of pulmonary harm: chemical insult, oxidant generation, inflammatory amplification and matrix remodeling.

The researchers caution that their work is an in vitro investigation, conducted on a cancer-derived cell line at concentrations and durations that do not translate directly to real-world exposure scenarios. A549 cells, while a standard and widely used model of the alveolar epithelium, cannot reproduce the full complexity of lung tissue, the immune system or the metabolic processing of phthalates in the body. Nevertheless, the concordance between the pathways activated in these cultures and those documented in COPD patients lends biological plausibility to the epidemiological associations that have accumulated over the past two decades.

The study was supported by the Science and Engineering Research Board of the Department of Science and Technology, Government of India, under grant EEQ/2022/000034, and by a DST INSPIRE fellowship. As phthalates continue to accumulate in indoor environments and as COPD’s global burden grows, the authors argue that their findings underscore the need to treat inhalation exposure to dimethyl phthalate as a legitimate respiratory health risk, one that deserves the same regulatory scrutiny that other members of the phthalate family have begun to receive.